4.02
price down icon3.13%   -0.13
after-market Dopo l'orario di chiusura: 4.07 0.05 +1.24%
loading

Acurx Pharmaceuticals Inc Azioni (ACXP) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
5.61%
2.2697
2.1492 2.7818 2.8216 4.1218
Operating Income/Loss
4.28%
-2.2697
-2.1765 - - -
Income/Loss From Continuing Operations Before Tax
4.52%
-2.2463
-2.1492 -2.7818 -2.8216 -4.1218
Income/Loss From Continuing Operations After Tax
4.52%
-2.2463
-2.1492 -2.7818 -2.8216 -4.1218
Net Income/Loss
4.52%
-2.2463
-2.1492 -2.7818 -2.8216 -4.1218
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
94.06%
1.1903
20.04 0.2556 16.36 15.82
Diluted Average Shares
94.06%
1.1903
20.04 0.2556 16.36 15.82
Basic Earnings Per Share
1,618%
-1.89
-0.11 -0.16 -0.17 -0.26
Diluted Earnings Per Share
1,618%
-1.89
-0.11 -0.16 -0.17 -0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$34.90
price down icon 2.43%
$81.66
price down icon 2.97%
$28.84
price down icon 2.07%
$98.08
price down icon 1.67%
$135.59
price down icon 3.84%
biotechnology ONC
$328.71
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):